Redox Proteomics in Some Age-Related Neurodegenerative Disorders or Models Thereof

被引：6

作者：

Butterfield D.A. ^{[1
,2
]}

Abdul H.M. ^{[1
,2
]}

Newman S. ^{[1
,2
]}

Reed T. ^{[1
,2
]}

机构：

[1] Department of Chemistry, Center of Membrane Sciences, University of Kentucky, Lexington, KY

[2] Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY

来源：

NeuroRX | 2006年 / 3卷 / 3期

基金：

美国国家卫生研究院;

关键词：

(1-42); Aβ; AD; Alzheimer's disease; amyloid beta-peptide; mass spectrometry; protein oxidation; Redox proteomics;

D O I：

10.1016/j.nurx.2006.05.003

中图分类号：

学科分类号：

摘要：

Summary: Neurodegenerative diseases cause memory loss and cognitive impairment. Results from basic and clinical scientific research suggest a complex network of mechanisms involved in the process of neurodegeneration. Progress in treatment of such disorders requires researchers to better understand the functions of proteins involved in neurodegenerative diseases, to characterize their role in pathogenic disease mechanisms, and to explore their roles in the diagnosis, treatment, and prevention of neurodegenerative diseases. A variety of conditions of neurodegenerative diseases often lead to post-translational modifications of proteins, including oxidation and nitration, which might be involved in the pathogenesis of neurodegenerative diseases. Redox proteomics, a subset of proteomics, has made possible the identification of specifically oxidized proteins in neurodegenerative disorders, providing insight into a multitude of pathways that govern behavior and cognition and the response of the nervous system to injury and disease. Proteomic analyses are particularly suitable to elucidate post-translational modifications, expression levels, and protein-protein interactions of thousands of proteins at a time. Complementing the valuable information generated through the integrative knowledge of protein expression and function should enable the development of more efficient diagnostic tools and therapeutic modalities. Here we review redox proteomic studies of some neurodegenerative diseases. © 2006 The American Society for Experimental NeuroTherapeutics, Inc.

引用

页码：344 / 357

页数：13

共 134 条

[1]

Selkoe D.J., Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein, J Alzheimers Dis, 3, pp. 75-80, (2001)

[2]

Cruts M., van Broeckhoven C., Presenilin mutations in Alzheimer's disease, Hum Mutat, 11, pp. 183-190, (1998)

[3]

Slooter A.J., Cruts M., Kalmijn S., Hofman A., Breteler M.M., van Broeckhoven C., Et al., Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study. the Rotterdam Study, Arch Neurol, 55, pp. 964-968, (1998)

[4]

Olanow C.W., Tatton W.G., Etiology and pathogenesis of Parkinson's disease, Annu Rev Neurosci, 22, pp. 123-144, (1999)

[5]

Gandhi S., Wood N.W., Molecular pathogenesis of Parkinson's disease, Hum Mol Genet, 14, pp. 2749-2755, (2005)

[6]

Kurosinski P., Guggisberg M., Gotz J., Alzheimer's and Parkinson's disease. overlapping or synergistic pathologies?, Trends Mol Med, 8, pp. 3-5, (2002)

[7]

Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Et al., Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation, J Neurochem, 65, pp. 2146-2156, (1995)

[8]

Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J.B., Pierce W.M., Et al., Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1, Free Radic Biol Med, 33, pp. 562-571, (2002)

[9]

Castegna A., Aksenov M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., Et al., Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, α-enolase and heat shock cognate 71, J Neurochem, 82, pp. 1524-1532, (2002)

[10]

Castegna A., Thongboonkerd V., Klein J.B., Lynn B., Markesbery W.R., Butterfield D.A., Proteomic identification of nitrated proteins in Alzheimer's disease brain, J Neurochem, 85, pp. 1394-1401, (2003)

← 1 2 3 4 5 6 7 8 9 10 →